GeneDx CEO Katherine Stueland exercised 80,000 RSUs and sold 46,933 shares to fulfill tax obligations. The non-discretionary transactions occurred at average prices between $60.93 and $65.61, leaving her with 91,514 Class A shares plus more RSUs and options.

NodeGuardian

2026-04-18 14:05:09

Abstract generation in progress

GeneDx Holdings Corp. CEO Katherine Stueland exercised 80,000 restricted stock units (RSUs) and subsequently sold 46,933 shares to cover tax withholding obligations. These “sell to cover” transactions were non-discretionary and executed at weighted average prices between $60.93 and $65.61 per share. After these transactions, the CEO beneficially owns 91,514 shares of Class A common stock, along with additional RSUs and stock options.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
223.78K Popularity
#
Gate13thAnniversaryLive
747.09K Popularity
#
AltcoinsRallyStrong
7.35M Popularity
#
AnthropicvsOpenAIHeatsUp
1.08M Popularity
#
KalshiFacesNevadaRegulatoryClash
473.38K Popularity

Sitemap

GeneDx (WGS) CEO exercises 80K RSUs, sells 47K shares for taxes

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

AltcoinsRallyStrong

AnthropicvsOpenAIHeatsUp

KalshiFacesNevadaRegulatoryClash

Pin